is possible to argue that these activities may not be in the best interests of sound forward planning for the universities. It is equally possible to argue that the universities are not the ideal place for rapid progress in certain aspects of medical research.
The foundations have a special roleif they have sufficient funds, they can take a broader look at affairs and use their funds to stimulate changes or look after problems that are being left on one side because they lack emotional appeal or any obvious priority for a government. Often it is necessary to foster developments that tend to fall between the orbits of particular government organizations. Thus the Wellcome Trust has been able to help European cooperation in medical research, to foster tropical medicine, to encourage the development of neglected subjects, to launch an interdisciplinary approach to medical problems at the universities, and to associate veterinary and medical science. Alternatively, foundations may see the need for particular types of support, for example buildings, equipment, fellowships &c.
A much more difficult question to answer is: 'What is the value of all this research you have supported and can you point to some particular break-through which would not have occurred without you?'. My answer is that break-throughs are rare and are often a figment of the joumalistic mind. Knowledge tends to advance in a regular fashion and the identification of cures, breakthroughs and triumphs of brilliance is an artificial exercise. What is important is that there is a continuing strong activity in medical research in this country which is leading to continual advance as well as maintaining the standards of our universities, medical schools and hospitals, and leading to the highest standards of medical practice.
I hope I have shown that private funds are contributing very considerably to this situation; in some subjects in a very major way,for example, the cancer funds. It is not so much the advances that come from research, although these are considerable, but the whole standard of medicine and medical care that depends on continuing high quality medical research and a balance between the academic and the operational.
There are many questions that can be asked about the activities of these private funds. Their mechanism of action varies with their organization and their interests. Many jealously guard their independence from government. They try, however, to avoid overlap. In recent years some of them have begun to meet together to discuss problems of mutual interest. There may be room for improvement in the way they choose to distribute their funds but it is not difficult to imagine what would happen if they were reduced or eliminated.
Various problems are likely to face these private funcs in the future. Subscriptions may decrease and inflation will certainly decrease their value; there could be suggestions for a change in the taxation status of charities and government could wish to increase the centralization in the organization of research. While these factors may affect the availability of funds there are, unfortunately, other factors also which are already affecting their usefuhnew, especially for fundamental research. These include a changed attitude towards research in the community at large. Service is now more popular than academic success. Associated with this is a relative poorness of reward both financially and socially for those who pursue knowledge rather than profits. The effect of these social changes as well as the deadening effect of inflation and reduced budgets, is lessening recruitment and interest in research.
Conclusion
More than ever before, the private funds will be essential to maintain the impetus of researcb. I fear, however, that as they become more necessary, their relative quantity will be less. The only answer is to see that they are given with increased precision to ensure that they are put to the most Drofitable use. The Government allots a position of privilege to charities. Exemption from corporation tax on their investment income, the reclamation of income tax on donations made under deed of covenant, and the recent, although for the great majority of charities, not very significant (confidential report by Binder, Hamlyn & Co. to the National Council of Social Service), extension of tax exemption on legacies to charitable organizations (Finance Act 1972) together constitute a fiscal benefit, if a modest one, which has not been provided without some reason. As a result of the information gained by writing to my colleagues I estimate that the total sum foregone by the Treasury, and by the local authorities in discretionary rent rebates, in respect of both foundations and fund-raising charities supporting medical research, was a little in excess of £1.5 million last year.
REFERENCE
It is a long-standing cliche that voluntary bodies have a freedom to pioneer denied to organizations financed from public funds and Alexander Robertson, Executive Director of the (American) Millbank Memorial Fund, suggests that the rationale for 'the foundations having been granted, through tax exemption, the exceptionally privileged position that they hold' is the Government's acceptance that there is a need for organizations with this broad freedom of research denied to the State itself (Robertson 1964) . This is to a certain extent so, but tax concessions, on both sides of the Atlantic, are something more than a gesture of encouragement to bodies complementary to those supported by the Government itself, for tax exemption is not restricted to organizations with objectives similar to those of governmentally supported bodies. Charitable bodies which have no governmental equivalents, and whose aims may not even have the wholehearted approval of the Government, also benefit from tax concessions. Although the freedom to pioneer or experiment as well as the capabilities of speedy action, both difficult for governmental bodies, may be encouraged by the State through its tax system, the recognition of voluntary action as part of the traditional way of life in the West is a more important factor in the now very long-established attitude of Government to charities.
Of course the Government is immensely inconsistent in the distribution of its fiscal favours. For instance, while it allows a charitable body to reclaim tax already paid by the donor on the sum donated, if under deed of covenant, it insists on the repayment of a proportion of this refund if it is used for the purchase of research equipment. An additional 10% Value Added Tax is charged on the scientific equipment purchased with this donation.1 It is not easy to identify the dividing line between the type of research which I take to be the proper responsibility of, for instance, the Medical Research Council and that which a voluntary body should be supporting. But the 'Since this paper was given the supply of medical and scientific equipment purchased with charitable or voluntarily subscribed funds has been zero-rated (VAT (Donated Medical Equipment) Order 1974). differences between the types of research are, after a period of twenty-one years, at last becoming clearer to me and I will attempt to describe this clarification which I am only now beginning to discern.
Before saying more, however, I should make it clear that nongovernmental bodies do not exist for the purpose of filling gaps left by governmentsupported bodies in their own areas of research. This is evident from the nature of the funds at the disposal of nongovernmental organizations. These funds, besides being supplemented by a remission of or exemption from tax, which in itself implies an intrinsic difference, were originally provided voluntarily either by the founder of a trust or from the contributions of the general public. They consequently enjoy a greater latitude of application than monies which have been extracted by the Inland Revenue or Her Majesty's Board of Customs and Excise, even if from identical sources, and which, without consultation with the providers, are diverted by the Treasury, through one or other of the official channels, towards medical research. This is not to discourage the flow of funds from the Treasury. On the contrary! But it is understandable that the Treasury should look hard at the expenditure of 'extracted' money. As Lord Rothschild has recently made abundantly clear, there are constraints on research financed in this way which do not apply to soft money from nongovernmental organizations (Rothschild Committee 1971). The Medical Research Council, the University Grants Committee and other 'official' bodies are certainly suffering stringent financial restrictions at the present time, but the nongovernmental organizations have different responsibilities and I would like to show you where they lie.
(1) There is the facility to provide the freedom and speed of action to which reference has already been made. The facility of promoting adventurous and imaginative research is an extremely important and valuable feature in nongovernmental grant-making.
(2) The nongovernmental bodies have an ability and responsibility to look at medical research from an objective viewpoint difficult for the scientist deeply involved in his own specialty. This objectivity, coupled with the importance of the existence of more than one source of subvention for the research worker, prevents a monopoly from developing but, perhaps more importantly, it helps to set the whole range of medical research needs in perspective and to compensate for the scientist's understandable fascination with his own scientific enigmas.
(3) The third aspect was identified by R A Smith, Professor of Physics at the Massachusetts Institute of Technology, when he said, 'Let us recognize at once that one cannot "Qrganize" research, but one can create conditions under which research will flourish' (Smith 1966). And 'conditions' are not the bricks and mortar or even the existence of an academic department which must be the responsibility of the university to provide from its own funds, but rather the ambience of scientific thought and discussion and curiosity.
(4) The fourth aspect was referred to by Frank Fremont-Smith (1964) when he pointed out that there are no sharp boundaries between the different branches of science and that any field of science may give unexpected assistance to some phase of medical investigation: 'Nature is all of one piece.' It is therefore essential that a body supporting research should support it in such a way that interdisciplinary communication and the consequent crossfertilization of ideas may develop unimpeded.
(5) Alexander Robertson (1964) added another aspect when he said, 'Nongovernmental bodies should help to show the way to train men and women capable of giving leadership in research.'
These five points are to a certain extent relevant to all medical research but, I suggest, particularly relevant to the research supported by nongovernmental organizations.
Applicants for grants know that however vehemently a voluntary body may declare its interest in supporting 'adventurous' research, there have to be manifest good sense and intelligent planning behind any proposal likely to succeed. It is to be remembered too that important discoveries are not isolated phenomena but, when they do come, they almost certainly burst from a background of classic, even pedestrian, research. As for the bodies which support medical research, if they are sympathetic and indeed generous to those putting forward ingenious and provocative proposals they will be encouraging those who can obtain little encouragement or support elsewhere. Nor should this help be restricted to those who submit applications. The foundation or voluntary body will do well to identify areas where research is needed and then seek the young scientist likely to turn an eager and imaginative mind to the subject.
Another way of supporting medical research is by the endowment of professorial chairs and we might usefully spend a few moments considering the advantages and disadvantages of this method.
The aim of bodies promoting medical research, including voluntary bodies, is not limited to the provision of tidy answers to specific questions on a-customer-contractor basis but is directed at an expansion of the whole range of knowledge in the area with which the body is concerned, whether it is medicine generally or physical disability or the narrower area of a single disease or condition. This lies somewhere between Lord Rothschild!s principles of applied research and development and his description of basic research, 'basic, fundamental or pure research', which he admits has no analogous customer-contractor basir (Rothschild Committee 1971) .
Is the endowment of a chair in order to achieve this expansion of knowledge truly productive or is it wasteful? Substantial funds are, of course, needed for such endowments and a university seeking an endowment today would certainly need £200 000 or £250 000, a figure which will certainly increase in the present general economic climate.
Sums of this size are not lightly dispensed by voluntary organizations, but there seems to be no doubt that the universities seek this type of endowment in spite of the immediate and future heavy additional commitments in which an endowed chair necessarily involves the university.
It should be emphasized that no outside body would, or could, endow a chair without the approval of the university and indeed without an actual request from the university. The National Fund for Research into Crippling Diseases has just announced the endowment of two research chairs to mark its twenty-first anniversary. The National Fund advertised its willingness to consider applications for these two chairs at £200000 each and 39 submissions were received. It is significant that within the relatively narrow limits of physical disability, universities believe that there is a need for a research chair in 39 separate instances. Even if it is claimed that some of the applications resulted from a euphoric optimism on the part of a Vice-Chancellor or the Dean of a Faculty, the figure would still be substantial enough to demonstrate a disturbing lack of facilities and resources for medical research generally. Although one or two of the submissions would have had low priorities in anybody's book, except presumably the applicant's, none of the proposals was devoidof scientific substance.
The body endowing a research chair will think it essential that the incumbent of its chair should be a research scientist and that extraneous departmental duties should divert him and his colleagues as little as possible from the prosecution of their research. The National Fund, in the endowments referred to, stipulated that each proposed chair should be a research chair in, or in association with, an existing department. Under such an arrangement others will already have responsibility for much of the clinical work and the teaching load. Furthermore, it is likely that the administration and the administrative expenditure of the research chair will be reduced to a minimum, if not_completely absorbed in an already existing administrative structure.
The creation of 'conditions under which research can flourish', the encouragement of interdisciplinary communication and the training of the future leaders of research can, I suggest, only be pursued with any likelihood of success within an academic environment. The more centres of research that can be set up in such an environment the better will be the research conditions, the lines of communication and the training of research leaders.
However, the most valuable feature of the professorial department has yet to be mentioned. This is its ability to attract further funds from many different quarters in a way which would be impossible if it had not been accorded professorial status.
To sum up, the nongovernmental organization, provided it has sufficient funds, should in the support of project research be particularly sympathetic to the young, the adventurous and the 'nonestablishment'. It should support research centres, establishing appropriate professorial and other departments which can reasonably be expected to develop into centres of excellence.
Finally, I would remind every trustee, referee and administrator of a research-supporting organization, of Dr Johnson's comment to Lord Chesterfield in 1755: 'Is not a patron, my Lord, one who looks withoutconcern on a man struggling for life in the water and, when he has reached ground, encumbers him with help?' Mr Gordon Piller (Leukamia Research Fund, 61 Great Ormond Street, London WCIN3JJ)
Character ofNongovernmental Funds in Support ofResearch
The maintenance of the impetus of research is always a major problem in the economy of medical institutions for rarely is there a satisfactory balance of the essentials-money, manpower and space. The practice of research usually stems from the special interests or observations of individuals within a university department or hospital. Much of this activity will be project research conducted or supervised by an individual researcher, dependent upon short-term finance. Subject research which requires long-term and major finance involves the acceptance of it by the institution as a whole and may be sought or offered for a variety of academic and other reasons. The third category of research is that which has already been mentioned-the work carried on by university staff within their academic appointments.
It is the support of the first two categories of research that concerns the private grant-giving organizations, or individuals. How, much the university departments and hospitals are dependent on private funds can be estimated by taking two important fields of medical researchchild health and cancer.
In an analysis of research carried out at Departments of Child Health and their associated children's hospitals in 1973 (Table 1) , 60%was supported by private funds. This fact is not sur- prising for a number of reasons: (1) Government funds are provided on an annual basis and issued against estimates and budgets, and quinquennial funds are subject to priorities often determined well in advance.
(2) Government research funds are subject to political considerations, squeezes, cut-backs, development plans and the like, which make the availability of funds difficult to determine. There is constant competition for the
